Chalcones as Promising Lead Compounds on Cancer Therapy

Author(s): Antonio J. Leon-Gonzalez, Nuria Acero, Dolores Munoz-Mingarro, Inmaculada Navarro, Carmen Martin-Cordero

Journal Name: Current Medicinal Chemistry

Volume 22 , Issue 30 , 2015

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


Chalcones constitute a group of phenolic compounds that command an increasing interest on cancer research. Natural chalcones are widespread through the plant kingdom. The most abundant and investigated chalcones are isoliquiritigenin, flavokawain and xanthohumol, which are present in the Fabaceae, Piperaceae, Cannabaceae, and Moraceae families. These chalcones have been shown to be promising lead antitumor-chemopreventive drugs by three different activities: antioxidants, cytotoxic and apoptosis inducers. In the recent years, SAR (structure-activity relationship) has contributed towards the improvement of anticancer properties of chalcones by substituting aryl rings and introducing heterocyclic moieties. This review summarizes the anticancer activities shown by natural chalcones and the SAR and describes how different chemical moiety modifications could lead them to be therapeutically useful in the treatment of cancer.

Keywords: Apoptosis, cancer, chalcone, chemoprevention, flavonoid, synthesis, tubulin.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Page: [3407 - 3425]
Pages: 19
DOI: 10.2174/0929867322666150729114829
Price: $65

Article Metrics

PDF: 85
PRC: 1